Astria Therapeutics earnings were -$94.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ATXS earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$25.6M, up 4.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ATXS reported annual earnings of -$94.3M, with 29.3% growth. The next ATXS earnings date is May 7, 2025.
Astria Therapeutics Earnings Reports & History FAQ
What were Astria Therapeutics's earnings last quarter?
On ATXS's earnings call on Invalid Date, Astria Therapeutics (NASDAQ: ATXS) reported Q4 2024 earnings per share (EPS) of -$0.44, up 53.19% year over year. Total ATXS earnings for the quarter were -$25.63 million. In the same quarter last year, Astria Therapeutics's earnings per share (EPS) was -$0.94.
The next ATXS earnings date is Invalid Date. Add ATXS to your watchlist to be reminded of Astria Therapeutics's next earnings date.
What was ATXS's earnings growth in the past year?
As of Astria Therapeutics's earnings date in Invalid Date, Astria Therapeutics's earnings has grown year over year. ATXS earnings in the past year totalled -$94.26 million.
Is Astria Therapeutics profitable or losing money?
As of the last Astria Therapeutics earnings report, Astria Therapeutics is currently losing money. Astria Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$94.26 million, a 29.32% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.